The market appears to be taking into account the future earnings per share (EPS) generated by the inclusion of new plants in Chennai and Mundra. This anticipation has led to a perceived reevaluation of the company’s market capitalization. Currently, the stock is trading at a ratio of 1:1 in comparison to the market capitalization to revenue, which seems relatively lower compared to industry peers. The addition of these plants is expected to contribute positively to the company’s overall revenue, and investors seem to be factoring in the potential impact on the stock’s valuation.
| Subscribe To Our Free Newsletter |
